More importantly, Kaplan–Meier survival analysis unveiled a substantial association of CCDC86 expression with overall survival and disease-free survival in glioma patients (Fig. 1B), highlighting its potential as a prognostic marker for this disease. The gene discussed is CCDC86; the disease is glioma.